• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library

    Astellas`s Biologics Vyloy Receives Suppl Approval in US

    FDA

    Astellas Pharma`s Vyloy Receives Approval in Canada

    HEALTH CANADA

    Astellas Pharma`s Veozah Receives Approval in Canada

    HEALTH CANADA

    Astellas`s Biologic Vyloy (Zolbetuximab) Receives Approval in US

    FDA

    Astellas Pharma`s Vyloy (zolbetuximab) Receives Approval in Europe

    EMA

    Astellas` Biologic Padcev (enfortumab vedotin) Receives Approval in the U.S.

    FDA

    Astellas`s Biologic Padcev (Enfortumab vedotin) Receives Approval in the U.S.

    FDA

    Astellas` Biologic Padcev (Enfortumab Vedotin) Receives Approval in the U.S.

    FDA

    Astellas Pharma Padcev Enfortumab vedotin Receives Approval in Europe

    EMA

    Astellas`s Biological Enfortumab Vedotin-Ejfv Receives Supplemental Approval In US

    FDA

    Astellas`s Padcev (Enfortumab vedotin) Receives Supplimental Approval in US

    FDA

    Osi`s Tarceva (Erlotinib Hcl) Receives Supplemental Approval in USA For Lung Cancer

    FDA

    Astellas Cresemba (Isavuconazonium Sulfate) Approved In USA For Invasive Aspergillosis and Invasive Mucormycosis

    ASTELLAS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.